1824-96-0

Basic information

• Product Name: .alpha.-D-Xylofuranoside, methyl
• Synonyms: .alpha.-D-Xylofuranoside, methyl;Methyl a-D-xylofuranoside;a-D-Xylofuranoside, Methyl;Methyl alpha-D-xylofuranoside
• CAS NO: 1824-96-0
• Molecular Formula: C₆H₁₂O₅
• Molecular Weight: 164.16
• Mol File: 1824-96-0.mol
• Article Data: 84

Chemical Properties

• Appearance: /
• Density: 1.40
• CAS DataBase Reference: .alpha.-D-Xylofuranoside, methyl(CAS DataBase Reference)
• NIST Chemistry Reference: .alpha.-D-Xylofuranoside, methyl(1824-96-0)
• EPA Substance Registry System: .alpha.-D-Xylofuranoside, methyl(1824-96-0)

Safety Data

• Hazardous Substances Data: 1824-96-0(Hazardous Substances Data)

Usage

General Description

.alpha.-D-Xylofuranoside, methyl, also known as methyl .alpha.-D-xylopyranoside, is a chemical compound derived from xylose, a type of sugar. It is a methylated form of xylose and is often used as a precursor in the synthesis of various pharmaceuticals and natural products. .alpha.-D-Xylofuranoside, methyl is commonly used in organic chemistry research, particularly in the study of carbohydrate structures and reactions. It has a molecular formula of C6H12O5 and a molecular weight of 164.16 g/mol. Methyl .alpha.-D-xylopyranoside is a white, crystalline solid that is soluble in water and organic solvents, making it a versatile compound for use in various chemical reactions.

Upstream product

• 67-56-1 methanol 
• 58-86-6 D-xylose 
• 1114-34-7 D-lyxose 
• 532-20-7 D-lyxose 
• 87-72-9 D-lyxose 
• 50-69-1 D-ribose 
• 532-20-7 D-Ribose 
• 189129-08-6 C₃₀H₂₆N₄O₈ 
• 850252-47-0 (4S,1'R)-4-(1'-hydroxy-2',2'-dimethoxyethyl)-2,2-dimethyl-1,3-dioxan-5-one 
• 1417423-72-3 C₁₃H₂₄O₆ 
• 875903-74-5 (4R,5R)-4-((R)-1-hydroxy-2,2-dimethoxyethyl)-2,2-dimethyl-1,3-dioxan-5-ol 
• 1417423-79-0 C₁₃H₂₆O₆ 
• 75-36-5 acetyl chloride 
• 10257-32-6 D-ribose 

Downstream Products

• 2296-41-5 methyl-tri-O-methyl-arabinofuranoside 
• 64363-77-5 methyl 2,3,5-tri-O-benzyl-D-ribofuranoside 
• 197716-38-4 2,3,5-tri-O-benzyl-1-O-methyl-D-xylofuranoside 
• 50908-04-8 (-)-Methyl-5-O-trityl-β-D-ribofuranosid 
• 67689-93-4 methyl 5-O-trityl-α-D-ribofuranoside 
• 79083-40-2 2,3,5-tri-O-benzyl-1-O-methyl-α-D-xylofuranoside 
• 79083-41-3 2,3,5-tri-O-benzyl-1-O-methyl-β-D-xylofuranoside 
• 52783-53-6 methyl 2,3,3'-tri-O-benzoyl-β-D-apiofuranoside 
• 52783-87-6 methyl 2,3,5-tri-O-benzoyl-α-D-ribofuranoside 
• 69350-76-1 methyl 2,3,5-tri-O-benzoyl-αβ-D-ribofuranoside 
• 86042-33-3 methyl 2,3,5-tri-O-p-toluyl-D-ribofuranoside 
• 108008-65-7 methyl 2,3,5-tri-O-(4-chlorobenzyl)-β-D-ribofuranoside 
• 59279-37-7 methyl 2,3,5-tri-O-(p-nitrobenzoyl)-β-D-ribofuranoside 
• 13039-66-2 α- and β-methyl 5-O-(p-toluenesulfonyl)xyloside 

Relevant articles and documents

MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

The present disclosure provides oligomeric compounds comprising a modified oligonucleotide having at least one stereo-non-standard nucleoside. An oligomeric compound comprising a modified oligonucleotide consisting of 12-30 linked nucleosides, wherein at least one nucleoside of the modified oligonucleotide is a stereo-non-standard nucleoside; and wherein the oligomeric compound is selected from among an RNAi compound, a modified CRISPR compound, and an artificial mRNA compound.

Novel saccharide bio-based cyclic phosphorus/phosphonate as well as preparation method and application thereof

The invention discloses novel saccharide bio-based cyclic phosphorus/phosphonate as well as a preparation method and application thereof, and belongs to the field of compounds. The cyclic phosphorus/phosphonate is prepared by the following steps: reacting D-xylose with acetyl chloride to obtain an intermediate product, and then reacting with dichlorophosphate or phosphonic dichloride under the action of an acid-binding agent to obtain a target product. The preparation method is high in yield, simple in process, low in raw material cost and small in environmental pollution, and the prepared cyclic phosphorus/phosphonate flame retardant is outstanding in flame retardance and easy to industrialize.

ANTIVIRAL NUCLEOSIDES AND DERIVATIVES THEREOF

Disclosed herein are nucleoside compounds and derivatives thereof, pharmaceutical compositions containing same, and their methods of synthesis. The compounds are useful in treating orthomyxovirus infections, such as influenza infections.